{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:49:43Z","timestamp":1783392583544,"version":"3.54.6"},"reference-count":25,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Contact Dermatitis"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Allergic contact dermatitis (ACD) caused by topical ophthalmic medications is often overlooked.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To study the demographic characteristics, lesion locations and associated medical conditions of the patients with ACD caused by ophthalmic drugs, and to identify the most common allergenic culprits, as well as trends in frequencies over the years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From January 1990 until December 2016, 16 065 patients were investigated in our clinic; all patients with a positive patch test reaction to an eye medication or its ingredient(s) having caused ACD were assessed. For each allergen identified, the number of positive test results as compared with the total number of those in the total population, as well as trends across three periods, namely 1990 to 1998, 1999 to 2007, and 2008 to 2016, were studied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and eighteen patients (0.7%) presented with positive patch test reactions to ingredients of and\/or topical ophthalmic medications. Aminoglycoside antibiotics, followed by corticosteroids, as pharmacologically active ingredients, as well as wool alcohols, thiomersal, and benzalkonium chloride, as excipients, were the most frequent culprits. Chloramphenicol showed a decreasing trend of positive reactions over time, whereas reactions to tobramycin increased.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ACD caused by eye medication is mainly attributable to active principles, but other excipient ingredients, beside the products \u201cas is,\u201d should be tested as well.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cod.13209","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T15:07:03Z","timestamp":1547132823000},"page":"291-297","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Allergic contact dermatitis caused by topical ophthalmic medications: Keep an eye on it!"],"prefix":"10.1111","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-3104","authenticated-orcid":false,"given":"Liesbeth","family":"Gilissen","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Laboratory of Dermato\u2010Immunology KU Leuven  Leuven Belgium"},{"name":"Contact Allergy Unit, Department of Dermatology University Hospitals Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"De Decker","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences KU Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Hulshagen","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences KU Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-3439","authenticated-orcid":false,"given":"An","family":"Goossens","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Laboratory of Dermato\u2010Immunology KU Leuven  Leuven Belgium"},{"name":"Contact Allergy Unit, Department of Dermatology University Hospitals Leuven  Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2010.11.008"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000000723"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08790.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2009.07216_supp.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12695"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1998.tb05645.x"},{"key":"e_1_2_8_8_1","volume-title":"Patch\u2010testing. Test Concentrations and Vehicles for 4350 Chemicals","author":"Groot AC","year":"2008"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12432"},{"key":"e_1_2_8_10_1","unstructured":"Farmanet database of Rijksinstistuut voor ziekte\u2010 en invaliditeitsverzekering (RIZIV).https:\/\/www.inami.fgov.be\/nl\/statistieken\/geneesmiddel\/Paginas\/statistieken\u2010geneesmiddelen\u2010farmanet\u201001.aspx. Accessed February 19 2019."},{"key":"e_1_2_8_11_1","first-page":"559","article-title":"Allergic contact stomatitis","volume":"123","author":"Feller L","year":"2017","journal-title":"Oral Medicine"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00588.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304197"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12157"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02666.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2001.450519.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12939"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajcd.2002.30720"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2007.01126.x"},{"key":"e_1_2_8_20_1","first-page":"18","article-title":"Dermatite allergica da contatto delle palpebre da topici oftalmici. Il ruolo dei beta\u2010bloccanti: problemi di diagnosi e gestione","volume":"61","author":"Nino M","year":"2007","journal-title":"Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale"},{"key":"e_1_2_8_21_1","first-page":"328","article-title":"Allergic contact dermatitis due to beta\u2010blocker agents in eye drops: relevance of patch testing versus open use testing (ROAT)","volume":"21","author":"Vandebuerie L","year":"2011","journal-title":"Nederlands Tijdschrift voor Dermatologie en Venereologie"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000224"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2010.01710.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2010.03.001"},{"key":"e_1_2_8_25_1","unstructured":"Gecommentarieerd Geneesmiddelenrepertorium of Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI): chloramphenicol.http:\/\/www.bcfi.be\/nl\/gows\/2769. Accessed February 19 2019."},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0162"}],"container-title":["Contact Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcod.13209","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cod.13209","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cod.13209","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cod.13209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T17:01:53Z","timestamp":1694365313000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cod.13209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1111\/cod.13209"],"URL":"https:\/\/doi.org\/10.1111\/cod.13209","archive":["Portico"],"relation":{},"ISSN":["0105-1873","1600-0536"],"issn-type":[{"value":"0105-1873","type":"print"},{"value":"1600-0536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"2018-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}